From: A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
Symptoms | Population n (%) | Group Ia n (%) | Group IIb n (%) | p value ¥ |
---|---|---|---|---|
Data available | 46 (90%) | 24 (86%) | 22 (96%) | |
Fever | 40 (87%) | 20 (82%) | 20 (91%) | 0.446 |
Abdominal pain | 37 (80%) | 19 (79%) | 18 (82%) | 0.821 |
Arthralgia | 21 (46%) | 11 (46%) | 10 (46%) | 0.979 |
Asthenia | 13 (28%) | 5 (21%) | 8 (36%) | 0.243 |
Myalgia | 10 (22%) | 2 (8%) | 8 (36%) | 0.021 |
Thoracic pain | 9 (20%) | 4 (17%) | 5 (23%) | 0.605 |
Diarrhoea | 9 (20%) | 2 (8%) | 7 (32%) | 0.045 |
Amyloidosis | 9 (20%) | 9 (38%) | 0 (0%) | 0.001 |
Skin rash | 8 (17%) | 2 (8%) | 6 (27%) | 0.090 |
Arthritis | 7 (15%) | 5 (21%) | 2 (9%) | 0.268 |
Peritonitis | 6 (13%) | 3 (13%) | 3 (14%) | 0.909 |
Vomiting | 5 (11%) | 4 (17%) | 1 (5%) | 0.187 |
Headache | 5 (11%) | 1 (4%) | 4 (18%) | 0.127 |